Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Marc Bourgault who wrote (4327)	5/18/1998 7:28:00 PM
From: Steve Fancy	Read Replies (2) of 6136

Marc, I don't believe I'm hitting Ms Wang. I only stated the facts as I see them. If the stock is annnnywhere close to her price target a year from say the last earnings report (have to pick a point in time somewhere) I'll have much greater respect for her. In the meantime, she certainly stands in a league all her own with her price target. I believe the $45 - $51 range suggested by other analysts is much more realistic, and in reality, a reasonable gain from where we're at. I was only suggesting that her unbending price target established for so long, was likely the reason she doesn't seem to command a lot of influence over the market. sf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next